AstraZeneca opened its global headquarters and research and discovery centre at the £1billion Discovery Centre (the DISC) on ...

AstraZeneca has briefed councillors on their plans to build a new office and conference centre at the Cambridge Biomedical ...

There were 725 residential building permits issued in Greater Boston through the first nine months of last year, down from 1,276 in 2022 and 1,710 in 2021, The Boston Globe reported.

The U.K. biopharmaceutical giant’s plans include a proposal for a new drug substance manufacturing center focused on ...

Cambridge life science neighbours Sortera Bio and AstraZeneca have added extra oomph to their fledgling partnership. In terms ...

AstraZeneca <AZN.L> is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry sources ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

A review of the last 10 years of partnership focusing on scientific collaboration, nurturing talent and strengthening our ecosystem.

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

AstraZeneca said the “cornerstone” of the commitment would be a new weight management production facility for its oral GLP-1 ...